Focusing on miR-410-3p, Li et al. demonstrated that a high level of miR-410-3p inhibited the proliferation, migration, and invasion of glioma cells through the inhibition of the transforming growth factor-ß receptor type 2 (TGFBR2) gene under Propofol treatment [59]. Here, TGFBR2 is linked to central nervous system cancer.